drugset / Trial / NCT00000597

Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

NCT00000597

RandomizedTreatment

Summary

To determine the therapeutic effects of anti-thymocyte globulin (ATG) in patients with aplastic anemia and related bone marrow failure diseases.

Timeline

Start
1982-03
Primary completion
Completion
1988-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nandrolone Other / unclassified
Subject antilymphocyte serum Protein / enzyme biologic